Globus Medical Inc
NYSE:GMED
Globus Medical Inc
NYSE:GMED
Price:
50.55 USD
0.36%
Market Closed
Updated:
Apr 28, 2024
Globus Medical Inc
Cash from Operating Activities
|
Globus Medical Inc
Cash from Operating Activities Peer Comparison
Comparables:
BDX
BSX
SYK
ABT
ISRG
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Globus Medical Inc
NYSE:GMED
|
Cash from Operating Activities
$243.5m
|
CAGR 3-Years
7%
|
CAGR 5-Years
6%
|
CAGR 10-Years
10%
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Cash from Operating Activities
$3.4B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
4%
|
CAGR 10-Years
8%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Cash from Operating Activities
$2.5B
|
CAGR 3-Years
18%
|
CAGR 5-Years
52%
|
CAGR 10-Years
8%
|
|
|
Stryker Corp
NYSE:SYK
|
Cash from Operating Activities
$3.7B
|
CAGR 3-Years
4%
|
CAGR 5-Years
7%
|
CAGR 10-Years
7%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Cash from Operating Activities
$7.3B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
4%
|
CAGR 10-Years
9%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Cash from Operating Activities
$1.7B
|
CAGR 3-Years
2%
|
CAGR 5-Years
7%
|
CAGR 10-Years
8%
|
See Also
What is Globus Medical Inc's Cash from Operating Activities?
Cash from Operating Activities
243.5m
USD
243.5m
USD
Based on the financial report for Dec 31, 2023, Globus Medical Inc's Cash from Operating Activities amounts to 243.5m USD.
What is Globus Medical Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
10%
10%
Over the last year, the Cash from Operating Activities growth was 36%. The average annual Cash from Operating Activities growth rates for Globus Medical Inc have been 7% over the past three years , 6% over the past five years , and 10% over the past ten years .
You don't have any saved screeners yet
